Skip to main content
NIH Intramural Research Program, Our Research Changes Lives

Navigation controls

  • Search
  • Menu

Social follow links

  • Podcast
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
      • Nobel Prize
      • Lasker Award
      • Breakthrough Prize
      • Presidential Early Career Award for Scientists and Engineers (PECASE)
      • Presidential Medal of Freedom
      • National Medal of Science
      • Searle Scholars
      • The National Academy of Sciences
      • The National Academy of Medicine
      • The National Academy of Engineering
      • The American Academy of Arts and Sciences
      • National Medal of Technology & Innovation
      • Samuel J. Heyman Service to America Medals
      • Crafoord Prize
      • Fellows of the Royal Society
      • Canada Gairdner Awards
    • Organization & Leadership
    • Our Programs
      • NCI
      • NEI
      • NHGRI
      • NHLBI
      • NIA
      • NIAAA
      • NIAID
      • NIAMS
      • NIBIB
      • NICHD
      • NIDA
      • NIDCD
      • NIDCR
      • NIDDK
      • NIEHS
      • NIMH
      • NIMHD
      • NINDS
      • NINR
      • NLM
      • CC
      • NCATS
      • NCCIH
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
      • Biomedical Engineering & Biophysics
      • Cancer Biology
      • Cell Biology
      • Chemical Biology
      • Chromosome Biology
      • Clinical Research
      • Computational Biology
      • Developmental Biology
      • Epidemiology
      • Genetics & Genomics
      • Health Disparities
      • Immunology
      • Microbiology & Infectious Diseases
      • Molecular Biology & Biochemistry
      • Molecular Pharmacology
      • Neuroscience
      • RNA Biology
      • Social & Behavioral Sciences
      • Stem Cell Biology
      • Structural Biology
      • Systems Biology
      • Virology
    • Principal Investigators
      • View by Investigator Name
      • View by Scientific Focus Area
    • Accomplishments
      • View All Accomplishments by Date
      • View All Health Topics
      • The Body
      • Health & Wellness
      • Conditions & Diseases
      • Procedures
    • Accelerating Science
      • Investing in Cutting-Edge Animal Models
      • Creating Cell-Based Therapies
      • Advancing Computational and Structural Biology
      • Combating Drug Resistance
      • Developing Novel Imaging Techniques
      • Charting the Pathways of Inflammation
      • Zooming in on the Microbiome
      • Uncovering New Opportunities for Natural Products
      • Stimulating Neuroscience Research
      • Pursuing Precision Medicine
      • Unlocking the Potential of RNA Biology and Therapeutics
      • Producing Novel Vaccines
    • Research in Action
      • View All Stories
      • Too Much of a Good Thing
      • Turning Face Perception on Its Head
      • Safeguarding a Second Chance at Life
      • A Biological Betrayal
    • Trans-IRP Research Resources
      • Supercomputing
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
      • Get Involved with Clinical Research
      • Physician Resources
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
      • Stadtman Tenure-Track Investigators
        • Science, the Stadtman Way
        • Earl Stadtman Investigator Frequently Asked Questions
      • Lasker Clinical Research Scholars
      • Independent Research Scholar
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
The NIH Catalyst: A Publication About NIH Intramural Research

National Institutes of Health • Office of the Director | Volume 23 Issue 5 • September–October 2015

Is Cancer Mainly Bad Luck? (Web Exclusive)

NIEHS Scientists Are Not Convinced

BY KELLY LENOX, NIEHS

A study published in the January 2, 2015, issue of Science that suggests that cancer is mainly bad luck spurred National Institute of Environmental Health Sciences (NIEHS) biostatisticians Clarice Weinberg and Dmitri Zaykin to take a closer look at how the data were interpreted (Science 347:78-81, 2015). Their analysis suggests that, as working with big data becomes the norm in biomedical research, it’s crucial to pay careful attention to analytical methods and how the results are interpreted.

The authors of the Science article claimed that “only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions [and that] the majority is due to ‘bad luck,’ that is, random mutations in normal, noncancerous stem cells.”

Clarice Weinberg
Dmitri Zaykin

BOTH: STEVE MCCAW, NIEHS

NIEHS biostatisticians Clarice Weinberg and Dmitri Zaykin challenged how data were interpreted in a study, published in Science, that concluded that cancer was just bad luck.

But Weinberg and Zaykin found fault with the Science paper’s logic. In a commentary published in the Journal of the National Cancer Institute, they called its conclusion—that most cases of cancer are fundamentally unpreventable because they are the result of chance—“unwarranted.” (J Natl Cancer Inst 107:djv125, 2015)

The Science authors reported an association between the logarithms of two variables: average lifetime incidence rates of 31 site-specific types of cancer, and the number of stem-cell divisions for the associated tissues. According to their analysis, two-thirds of the variation in cancer risk could be explained by the number of stem-cell divisions.

“There is value in pointing out this relationship in that the errors due to replication are probably causatively important,” Weinberg said. But “they went too far when they implied that inherited genetics and environmental factors could only explain about one-third of cancer.”

Weinberg, who is a senior investigator and head of the NIEHS Biostatistics and Computational Biology Branch, and Zaykin, a senior investigator in that branch, raised three statistical concerns: (1) the Science authors overinterpreted their R2 value; (2) using aggregated lifetime risk values likely led to overstating the impact of random errors in stem-cell replication; and (3) the notion that causes can be assigned fractions of risk that add up to 1.0 is false. Statisticians use a value called the coefficient of determination—R2 for short—to represent the correlation between two different measured variables. The closer the value is to 1.0, the more closely correlated the two variables are.

The Science article reported an R2 value of 0.65 and suggested that, therefore, 65 percent of the variation in cancer risk among different tissues could be explained by the number of stem-cell divisions in those tissues.

Terminology is crucial, according to Weinberg. “‘Explaining’ is statistical jargon that has little to do with causation—it has to do with the relationship between X and Y,” he said. “You can’t conclude from an R2 value how much of that causal relationship is due to the variable that X represents.”

Next, Weinberg and Zaykin expressed their concern about the use of aggregated lifetime risk data. “The R squared from an analysis of cancer types based on aggregated risk for each type obscures the contributions of individual risk factors to each cancer type,” they wrote..

Finally, they argued against partitioning causes into fractions that add up to 1.0. Referring to phenylketonuria, an inherited condition in which the body cannot properly metabolize phenylalanine, they wrote, “The fraction attributable to genetics is 1.0, while the fraction attributable to environment is also 1.0, because the outcome requires both a dysfunctional metabolic gene and an environmental exposure [dietary phenylalanine].”

“Weinberg and Zaykin make important points,” said NIEHS Scientific Director Darryl Zeldin. “The claim that two-thirds of the cancers studied are caused by bad luck could lead to an overemphasis on development of treatments at the expense of crucial research into prevention and the role that environmental and genetic factors play in the origins of cancer.”

Shyamal Peddada

Shyamal Peddada weighed in the the Science article, too.

NIEHS biostatistician Shyamal Peddada also weighed in, posting an online Science comment that the use of log-transformed data led to a faulty conclusion. “A correlation analysis of the raw data reveals a weak correlation,” he wrote. A similar point was made on PubMed Commons, which has received a dozen comments on the Science paper.

The public debate underscores the important contributions that biostatistics, data access, and open dialogue can make in ensuring that new scientific findings are properly interpreted so they can be confirmed and followed up by future studies.


REFERENCES

C. Tomasetti and B. Vogelstein, “Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions, Science 347, 78-81 (2015). [link: http://www.ncbi.nlm.nih.gov/pubmed/25554788]

C.R. Weinberg and D. Zaykin, “Is bad luck the main cause of cancer?” J Natl Cancer Inst 107, djv125 (2015) [link: http://www.ncbi.nlm.nih.gov/pubmed/25956173]

This page was last updated on Monday, April 25, 2022

  • Issue Overview
  • Features
    • Precision Psychiatry
    • Creating Devices for the Clinic
    • Recognition of Brilliant Scientific Work
    • Is Cancer Mainly Bad Luck? (Web Exclusive)
    • Three-Minute Talks
    • Hope, Science, and Miracles
  • Departments
    • From the Deputy Director for Intramural Research
    • Alumni News
    • Colleagues: Recently Tenured
    • News Briefs
    • Research Briefs
    • Photographic Moment
    • Photographic Moment (Web Exclusive)
    • Announcements
    • The Training Page
    • The SIG Beat
  • Issue Contents
  • Download this issue as a PDF

Catalyst menu

  • Current Issue
  • Previous Issues
  • About The NIH Catalyst
  • Contact The NIH Catalyst
  • Share Your Story
  • NIH Abbreviations

Catalyst links

  • Follow The NIH Catalyst

Subscribe Today!

Subscribe to The NIH Catalyst Newsletter and receive email updates.

Subscribe

Get IRP Updates

Subscribe

  • Email
  • Print
  • Share Twitter Facebook LinkedIn

Main navigation

  • About Us
    • What Is the IRP?
    • History
    • Honors
    • Organization & Leadership
    • Our Programs
    • Research Campus Locations
    • Contact Information
  • Our Research
    • Scientific Focus Areas
    • Principal Investigators
    • Accomplishments
    • Accelerating Science
    • Research in Action
    • Trans-IRP Research Resources
    • IRP Review Process
    • Commercializing Inventions
  • NIH Clinical Center
    • Clinical Center Facilities
    • Advancing Translational Science
    • Clinical Trials
  • News & Events
    • In the News
    • I am Intramural Blog
    • Speaking of Science Podcast
    • SciBites Video Shorts
    • The NIH Catalyst Newsletter
    • Events
  • Careers
    • Faculty-Level Scientific Careers
    • Trans-NIH Scientific Recruitments
    • Scientific & Clinical Careers
    • Administrative Careers
  • Research Training
    • Program Information
    • Training Opportunities
    • NIH Work/Life Resources
  • Department of Health and Human Services
  • National Institutes of Health
  • USA.gov

Footer

  • Home
  • Contact Us
  • IRP Brand Materials
  • HHS Vulnerability Disclosure
  • Web Policies & Notices
  • Site Map
  • Search